510(k) Report

510(k) · Cleared

Cleared

Tigertriever 13 Revascularization Device

K220808510(k) TraditionalCleared Jul 25, 2022129-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Rapid Medical, Ltd. · NRY Catheter, Thrombus Retriever

Cleared on Jul 25, 2022 as substantially equivalent to K203592 (Rapid Medical, Ltd., 2021) after a 129-day review. Its family tree reaches back 9 generations to 2001. 2 later devices descend from it.

Decided
Jul 25, 2022
Review
129 days
Class
Class II
Product code
NRY
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K003410 (2001). 15 ancestors in all. 2 later devices descend from it, 2 citing it directly.

  1. Root · 9 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 5 generations between
  3. 3 generations backK123378 Solitaire 2 Revascularization DeviceMicro Therapeutics Dba Ev3 Neurovascular · 2012
  4. 2 generations backK141491 Solitaire 2 Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2014
  5. 1 generation backK203592 Tigertriever and Tigertriever 17 Revascularization DevceRapid Medical, Ltd. · 2021
  6. This deviceK220808 Tigertriever 13 Revascularization DeviceRapid Medical, Ltd. · 2022
  7. Descendant · cites it directly · 0 of its ownK260617 Tigertriever 13 Ultra Revascularization DeviceRapid Medical Ltd. · 2026
  8. Descendant · cites it directly · 0 of its ownK230429 Tigertriever 21 Revascularization Device, Tigertriever 17…Rapid Medical, Ltd. · 2023
Show all 9 generations
  1. Root · 9 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 8 generations backK030476 Modified Concentric Retriever, Model 90037Concentric Medical, Inc. · 2003 · Recalled
  3. 7 generations backK033736 Merci Retriever, Models 90065, 90066Concentric Medical, Inc. · 2004
  4. 6 generations backK063774 Modification to Merci Retriever, Models X5 and X6Concentric Medical, Inc. · 2007
  5. 5 generations backK090085 Merci Retriever, Models 90050, 90060, 90066, 90070, 90110, 90111…Concentric Medical, Inc. · 2009
  6. 4 generations backK113455 Solitaire FR Revascularization DeviceMicro Therapeutics Dba Ev3 Neurovascular · 2012
  7. 3 generations backK123378 Solitaire 2 Revascularization DeviceMicro Therapeutics Dba Ev3 Neurovascular · 2012
  8. 2 generations backK141491 Solitaire 2 Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2014
  9. 1 generation backK203592 Tigertriever and Tigertriever 17 Revascularization DevceRapid Medical, Ltd. · 2021
  10. This deviceK220808 Tigertriever 13 Revascularization DeviceRapid Medical, Ltd. · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K260617Tigertriever 13 Ultra Revascularization DeviceRapid Medical Ltd. · 2026 · cites it directly0descendants
  • K230429Tigertriever 21 Revascularization Device, Tigertriever 17 Revascularization Device…Rapid Medical, Ltd. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K003410Concentric Retriever, Model 90030Concentric Medical, Inc.20011
−8K030476Modified Concentric Retriever, Model 90037Concentric Medical, Inc.20032
−7K033736Merci Retriever, Models 90065, 90066Concentric Medical, Inc.2004—
−6K063774Modification to Merci Retriever, Models X5 and X6Concentric Medical, Inc.2007—
−5K090085Merci Retriever, Models 90050, 90060, 90066, 90070, 90110, 90111, 90112, 90113Concentric Medical, Inc.2009—
−4K113455Solitaire FR Revascularization DeviceMicro Therapeutics Dba Ev3 Neurovascular2012—
−3K123378Solitaire 2 Revascularization DeviceMicro Therapeutics Dba Ev3 Neurovascular2012—
−2K141491Solitaire 2 Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2014—
−1K203592Tigertriever and Tigertriever 17 Revascularization DevceRapid Medical, Ltd.2021—
0 (this device)K220808Tigertriever 13 Revascularization DeviceRapid Medical, Ltd.2022—
+1K260617Tigertriever 13 Ultra Revascularization DeviceRapid Medical Ltd.2026—
+1K230429Tigertriever 21 Revascularization Device, Tigertriever 17 Revascularization…Rapid Medical, Ltd.2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610
200730
200820

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202610
FIG. 1 — Lineage of K220808, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NRY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NRY device

  1. #1 K232971 APRO 55 Catheter and Alembic Aspiration Tubingscore 18.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K203592Tigertriever and Tigertriever 17 Revascularization Devce
Summary page 4
…t Code: NRY Device Class: II Classification Panel: Neurology Legally Marketed Predicate Device(s) Tigertriever and Tigertriever 17 Revascularization Device (K203592) Indications for Use Statement The Tigertriever Revascularization Device is intended to restore blood flow by removing…
Rapid Medical, Ltd.2021—
†DEN170064Comaneci, Comaneci Petit, Comaneci 17Rapid-Medical, Ltd.2019—

Also cleared against K203592: 3 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260617Tigertriever 13 Ultra Revascularization DeviceRapid Medical Ltd.20260
K230429Tigertriever 21 Revascularization Device, Tigertriever 17 Revascularization Device…Rapid Medical, Ltd.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 1.9 years on median.
  • 3 of the 15 ancestors have a recall of any class.
  • Of its descendants, K260617 (Rapid Medical Ltd., 2026) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K203592.

How does its category compare?

All NRY devices

NRY Catheter, Thrombus Retriever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · NRY

15in 2025

2007: 52008: 22009: 22010: 12011: 22012: 42014: 42015: 62016: 52017: 32018: 112019: 72020: 62021: 92022: 32023: 82024: 82025: 152026 (partial year): 14
2007high 15 (2025) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NRY

129in 2025

2007: 94 days median2012: 90 days median2014: 140 days median2015: 128 days median2016: 75 days median2017: 185 days median2018: 156 days median2019: 89 days median2020: 125 days median2021: 80 days median2022: 129 days median2023: 112 days median2024: 165 days median2025: 129 days median2026 (partial year): 147 days median
2007high 185 (2017) · low 75 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NRY

4in 2020

2010: 12013: 12017: 42020: 4, 4 Class I2026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · NRY

565in 2025

2007: 132008: 182009: 572010: 2892011: 2632012: 3662013: 4052014: 4282015: 5982016: 4972017: 4322018: 4152019: 6502020: 7032021: 6882022: 5492023: 7112024: 6412025: 565
2007high 711 (2023) · low 13 (2007)2025

MAUDE reports naming product code NRY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007594013
20082—018
20092—057
20101—1289
20112—0263
20124900366
20130—1405
201441400428
201561280598
20165750497
201731854432
2018111560415
20197890650
202061254 (4)703
20219800688
202231290549
202381120711
202481650641
2025151290565
2026141472—

What is it indicated for?

The Tigertriever Revascularization Device is intended to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA), or who fail IV t-PA therapy, are candidates for treatment.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220808: Tigertriever 13 Revascularization Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220808

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026